Mark W Orme

USPTO Granted Patents = 68 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 5.1

ph-index = 15

Forward Citations = 1,266(Granted Patents)

Inventors with similar research interests:

Company Filing History:

University of Texas System

7. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2024

Loading Chart...

68 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12162871 - Inhibitors of VAP-1 (2024-12-10),

2. 12037334 - Inhibitors of VAP-1 (2024-07-16),

3. 12029708 - Alkoxy compounds for disease treatment (2024-07-09),

4. 11787791 - Inhibitors of VAP-1 (2023-10-17),

5. 11446261 - Alkoxy compounds for disease treatment (2022-09-20),

6. 10639286 - Alkoxy compounds for disease treatment (2020-05-05),

7. 10201545 - Styrenyl derivative compounds for treating ophthalmic diseases and disorders (2019-02-12),

8. 10188615 - Alkoxy compounds for disease treatment (2019-01-29),

9. 9737496 - Alkoxy compounds for disease treatment (2017-08-22),

10. 9464033 - Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders (2016-10-11),

11. 9458088 - Alkoxy compounds for disease treatment (2016-10-04),

12. 9452153 - Amine derivative compounds for treating ophthalmic diseases and disorders (2016-09-27),

13. 9447078 - Substituted heterocyclic compounds for disease treatment (2016-09-20),

14. 9421210 - Styrenyl derivative compounds for treating ophthalmic diseases and disorders (2016-08-23),

15. 9314467 - Styrenyl derivative compounds for treating ophthalmic diseases and disorders (2016-04-19),

Title: Unveiling the Inventive World of Mark W Orme

Introduction:

Mark W Orme is a prolific inventor hailing from Seattle, WA (US) with an impressive track record of 67 patents to his name. His innovative spirit and dedication to pushing boundaries in the field of science and technology have led to groundbreaking developments that have the potential to shape the future.

Latest Patents:

Among his latest patents is the creation of "Inhibitors of VAP-1," which introduces compounds and methods for modulating VAP-1 activity. Additionally, his work on "Alkoxy Compounds for Disease Treatment" showcases his contributions to treating neurodegenerative diseases, particularly ophthalmic conditions like age-related macular degeneration (AMD) and Stargardt's Disease.

Career Highlights:

Mark W Orme has made significant contributions to the innovations landscape through his tenure at companies like Acucela Inc. and Lilly Icos LLC. His expertise and ingenuity have been instrumental in driving forward advancements in the pharmaceutical and biotechnology sectors.

Collaborations:

Throughout his career, Mark W Orme has collaborated with esteemed professionals such as Vladimir Aleksandrovich Kuksa and Ian L Scott. These partnerships have not only enhanced the quality of his work but have also fostered a culture of innovation and excellence.

Conclusion:

In conclusion, Mark W Orme stands as a beacon of innovation, with his inventive prowess and relentless pursuit of scientific excellence shaping the realm of patents and inventions. His contributions have not only enriched the field of ophthalmic research but have also paved the way for future breakthroughs in the realm of neurodegenerative disease treatment. We eagerly anticipate the next chapter of innovation from this visionary inventor.

This text is generated by artificial intelligence and may not be accurate.